Cumberland Pharmaceuticals Inc.
Climate Impact & Sustainability Data (2021)
Reporting Period: 2021
Environmental Metrics
Waste Generated:4000+ pounds/year
ESG Focus Areas
- Environmental
- Social
- Governance
Environmental Achievements
- Safely disposed of over 4,000 pounds of expired and damaged products
- No product recalls
Social Achievements
- Provided nearly 2.5 million patient doses of its products
- No company brands listed on the FDA's MedWatch Safety Alerts for Human Medical Products
- No company product issues identified by FDA from its Adverse Event Reporting System
- No clinical trials terminated due to failure to practice good clinical standards
- National launch of RediTrex® with innovative delivery system
Governance Achievements
- Serialization of all commercial products sold in the U.S. to prevent counterfeit drugs
Climate Goals & Targets
Environmental Challenges
- Continued challenges of operating during a pandemic
Mitigation Strategies
- Diversified product portfolio mitigated negative effects of the pandemic